Mean | SD | |
---|---|---|
Disease severity | 3.58 | 0.75 |
Size of affected population | 3.58 | 0.75 |
Unmet needs | 3.01 | 0.55 |
Comparative effectiveness | 3.73 | 0.82 |
Comparative safety/tolerability | 3.58 | 0.98 |
Comparative patient-perceived health / PRO | 3.44 | 0.63 |
Type of therapeutic benefit | 3.58 | 1.17 |
Comparative cost consequences – cost of intervention | 3.58 | 0.75 |
Comparative cost consequences – other medical costs | 3.30 | 0.98 |
Comparative cost consequences – non-medical costs | 2.87 | 1.03 |
Quality of evidence | 4.01 | 0.52 |
Expert consensus/clinical practice guidelines | 3.44 | 0.63 |